Ginkgo biloba, one of the oldest species of trees, has existed on earth for 200 million years. The G. biloba leaves and seeds have been used in traditional medicine and food for thousands of years. Although numerous pharmacological effects and chemical components of G. biloba leaves extracts have been reported, few studies have been conducted on G. biloba seeds. In traditional food and medicine, G. biloba seeds have been used as supplementary materials for desserts, glazed fruits and beverages.
1 Some studies on the proteins of G. biloba seeds showed that the protein content of dry and defatted G. biloba seed powder was about 7%, and a number of proteins with antifungal and antioxidant activities were isolated. [2] [3] [4] [5] As part of our search for bioactive components from this valuable medicinal plant, 6 together with the methanol extract of G. biloba seeds was found to be active on NF-κB and PPARs transactivational effects during the preliminary screening process, the present study describes the isolation and structural elucidation of 13 compounds from the methanol extract of G. biloba seeds. The effects of compounds 1-13 on TNFα-induced NF-κB transcriptional activity in human hepatocarcinoma (HepG2) cells were evaluated using an NF-κB-luciferase assay. To confirm the inhibitory effects of the compounds on NF-κB transcriptional activity, the effects of the compounds on the upregulation of the pro-inflammatory proteins iNOS and COX-2 were assessed in TNFα-stimulated HepG2 cells by RT-PCR. Futhermore, the effects of compounds 1-13 on the transcriptional activity of PPARs and individual PPAR subtypes in HepG2 cells were also evaluated using a PPRE-luciferase and GAL4-PPAR chimera assays.
The MeOH extract of G. biloba seeds (200 g) was suspended in H 2 O and successively partitioned with n-hexane, CH 2 Cl 2 , and EtOAc to give four fractions. The aqueous fraction was subjected to multiple chromatographic steps over Diaion HP-20, silica gel, and reversed-phase C 18 , yielding compounds 1-13. By comparing the NMR and MS data with those reported in the literature, the structures of the isolated compounds were identified as: (2E,4E)-dihydrophaseic acid (1); C NMR and DEPT spectra indicated 15 carbons, including three methyl, three methylene, four methine, and five quaternary carbons. The
13
C NMR spectrum of 1 showed the presence of a carboxyl carbon (δ C 174.6, C-1), two double bonds [(δ C 127.2, C-2), (δ C 139.8, C-3), (δ C 132.1, C-4), and (δ C 129.2, C-5)], two oxygenated quaternary carbons [(δ C 86.8, C-5') and (δ C 82.2, C-8')], one oxymethylene (δ C 76.3, C-7'), one oxymethine (δ C 65.1, C-3'), and two methylenes [(δ C 43.5, C-2') and (δ C 45.0, C-4')], implying that 1 is a megastigmane. The position of the oxymethylene group at C-7' was assigned from the HMBC correlation of H 2 -7' to C-1, C-2', C-5', C-8', and C-1'. The positions of the two double bonds at C-2 and C-4 were assigned by HMBC correlations of H-2 to C-1, and C-6, H 3 -6 to C-2, C-3, and C-4, and H-5 to C-3, C-4, and C-8'. In the NOESY spectrum, the NOE correlations between H-2/H-4 and H-6/H-5 indicated E geometry of the two double bonds at C-2 and C-4. The NOE correlations between H 3 -10'/H-5 and H 3 -9'/H-5 suggested α-orientation of the hydroxyl group at C-8' and β-orientation of H 3 -10'. Moreover, the NOE correlations between H 3 -10'/ H-2'β, H-5/H-2'β, H-5/H-4'β, H-2'α/H-3', H-3'/H-4'α, and H-3'/H-7'β clearly indicated the α-orientation of H-3. Notes the first report of NMR data for (2E,4E)-dihydrophaseic acid.
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Cell viability was evaluated using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay (Promega Celltiter 96-Aqueous One Solution Assay) as described in Supporting information. The result showed that compounds 1-13 had no significant cytotoxicity toward HepG2 cells at the concentration of 10 μM (data not shown).
The anti-inflammatory activity of compounds 1-13 was evaluated through the inhibition of a TNFα-induced NF-κB luciferase reporter and by the attenuation of TNFα-induced pro-inflammatory gene (iNOS and COX-2) expression in HepG2 cells. The result showed that compounds 9 and 12 significantly inhibited TNFα-induced NF-κB transcriptional activity, with IC 50 values of 8.7 and 7.1 μM, respectively (Table 1) . Consistent with their inhibitory effects on NF-κB activation, compounds 9 and 12 significantly inhibited the induction of COX-2 and iNOS mRNA in a dose-dependent manner (Figure 2) , suggesting that the compounds reduced the transcription of these genes. Moreover, the housekeeping protein β-actin was unchanged by the presence of compounds 9 and 12 at the same concentrations.
The effects of compounds 1-13 on PPARs activation were evaluated using a PPRE-luciferase reporter assay. The result showed that compounds 4 and 13 significantly activated PPARs transcriptional activity, with EC 50 values of 8.5 and The values are mean ± SD (n = 3). Compounds 1-8, 10, 11 and 13 were inactive at tested concentrations. 17.0 μM, respectively (Table 2 ). Compounds 2, 3, and 6-10 displayed moderate activities, with EC 50 values ranging from 21.7 to 28.3 μM. Compound 5 weakly activated PPARs transcription, with an EC 50 value of 41.6 μM, whereas compounds 1, 11, and 12 were inactive at the experimental concentrations. Given these primary data, to determine specifically how the compounds modulate PPAR transcriptional activity, we further examined the PPAR transactivational effects of the isolated compounds on individual PPAR subtypes, including PPARα, γ, and β(δ). The results indicated that compounds 4 and 12 increased PPARα transcriptional activity, with EC 50 values of 47.7 and 53.3 μM, respectively. Compounds 6 and 8 activated PPARγ trascriptional activity, with EC 50 values of 53.4 and 50.4 μM, respectively, whereas compound 9 increased PPARβ(δ) transcriptional activity, with an EC 50 value of 52.8 μM (Table 2) . Taken together, this study provides scientific rationale for the use of G. biloba seeds in the prevention and treatment of inflammatory and metabolic diseases and warrants further studies of the potential of G. biloba seeds in functional foods and medicine.
Experimental
Plant Materials. The seeds of G. biloba were purchased from herbal market at Kumsan, Chungnam, Korea, in August, 2010. The plant material was identified by one of us (Y. H. Kim). A voucher specimen (CNU10110) was deposited at herbarium, College of Pharmacy, Chungnam National University.
Extraction and Isolation. The dried seeds (10.5 kg) were extracted three times with hot MeOH under reflux. After concentration, the MeOH extract (200 g) was suspended in H 2 O and then partitioned successively with n-hexane, CH 2 Cl 2 , and EtOAc to give n-hexane (sA, 110 g), CH 2 Cl 2 (sB, 1.1 g), EtOAc (sC, 1.3 g) and aqueous (sD, 80 g) fractions, respectively. The aqueous fraction sD was chromatographed on a column of highly porous polymer (Diaion HP-20) and eluted with a step-wise gradient of 0, 30, 60 and 100% (v/v) MeOH in H 2 O to give four fractions (sD1-sD4). Fraction sD2 (27 g) was separated by YMC RP column chromatography (CC), using MeOH-H 2 O (1:2) as eluents to give six subfractions (sD2.1-sD2.6). Compound 9 (7 mg) was isolated by silica gel CC, eluting with CH 2 Cl 2 -MeOH (9:1) from subfraction sD2.1 (200 mg). Subfraction sD2.2 was separated by CC over silica gel, eluting with CH 2 Cl 2 -MeOH (10:1), and further purified by silica gel CC, using CH 2 Cl 2 -acetone (2:1) as eluents, to obtain compounds 4 (9 mg) and 2 (6 mg). Compound 13 (11 mg) was isolated by preparative TLC using CH 2 Cl 2 -MeOH-H 2 O (4:1:0.1) from subfraction sD2.4 (50 mg). Subfraction sD2.3 (200 mg) was separated by silica gel CC, eluting with CH 2 Cl 2 -MeOH-H 2 O (5:1:0.1) to give two subfractions sD2.31-sD2.32. Compounds 6 (10 mg) and 7 (5 mg) were isolated by preparative TLC using CH 2 Cl 2 -MeOH-H 2 O (3:1:0.1) from subfractions sD2.31 (35 mg) and sD2.32 (42 mg), respectively. Compound 10 (8 mg) was isolated by CC over silica gel, eluting with CH 2 Cl 2 -MeOH (10:1) from subfraction sD2.6 (65 mg). Subfraction sD2.5 (0.3 g) was separated by silica gel CC, eluting with CH 2 Cl 2 -MeOH-H 2 O (6:1:0.1) to give two subfractions sD2.51-sD2.52. Compounds 1 (3 mg) and 3 (9 mg) were isolated by preparative TLC using CH 2 Cl 2 -MeOH-H 2 O (4:1:0.1) from subfractions sD2.51 (80 mg) and sD2.52 (66 mg), respectively. Fraction sD3 (8 g) was separated by silica gel CC, eluting with CH 2 Cl 2 -MeOH (10:1) to provide four subfractions (sD3.1-sD3.4). Compounds 8 (13 mg) and 5 (11 mg) EC50: the concentration of tested compound that gave 50% of the maximal reporter activity.
*
A compound is considered inactive with EC50 > 60 µM. n.d: not determined
